BIO & IPO Issue Statements on Biden Administration's Support for Proposed WTO Waiver

Publication Date07 May 2021
SubjectVaccinations,Coronavirus/COVID-19,Biden Administration,WTO,Biotechnology,Intellectual Property Protection,Pharmaceutical Industry,TRIPS Agreement
AuthorDonald Zuhn
Law FirmMcDonnell Boehnen Hulbert & Berghoff LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT